BIOMAT Database Logo BIOMAT Database Logo

Role of CYP3A in Oral Contraceptives Clearance. 2018

Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D003277 Contraceptives, Oral, Combined Fixed drug combinations administered orally for contraceptive purposes. Combined Oral Contraceptive,Contraceptive Agents, Female, Combined,Oral Contraceptives, Combined,Combined Oral Contraceptives,Contraceptive, Combined Oral,Contraceptives, Combined Oral,Oral Contraceptive, Combined
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D051544 Cytochrome P-450 CYP3A A cytochrome P-450 suptype that has specificity for a broad variety of lipophilic compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN. CYP3A,CYP3A4,CYP3A5,Cytochrome P-450 CYP3A4,Cytochrome P-450 CYP3A5,Cytochrome P-450IIIA,Cytochrome P450 3A,Cytochrome P450 3A4,Cytochrome P450 3A5,Erythromycin N-Demethylase,Taurochenodeoxycholate 6-alpha-Monooxygenase,3A5, Cytochrome P450,6-alpha-Monooxygenase, Taurochenodeoxycholate,Cytochrome P 450 CYP3A,Cytochrome P 450 CYP3A4,Cytochrome P 450 CYP3A5,Cytochrome P 450IIIA,Erythromycin N Demethylase,N-Demethylase, Erythromycin,P-450 CYP3A, Cytochrome,P-450 CYP3A4, Cytochrome,P-450 CYP3A5, Cytochrome,P-450IIIA, Cytochrome,P450 3A, Cytochrome,P450 3A5, Cytochrome,Taurochenodeoxycholate 6 alpha Monooxygenase
D065692 Cytochrome P-450 CYP3A Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. CYP3A Inhibitor,CYP3A5 Inhibitor,CYP3A7 Inhibitor,Cyp3A4 Inhibitor,Cytochrome P-450 CYP3A Inhibitor,Cytochrome P-450 CYP3A4 Inhibitor,Cytochrome P-450 CYP3A5 Inhibitor,Cytochrome P-450 CYP3A7 Inhibitor,P450 CYP3A Inhibitor,P450 CYP3A4 Inhibitor,P450 CYP3A5 Inhibitor,P450 CYP3A7 Inhibitor,CYP3A Inhibitors,CYP3A4 Inhibitors,CYP3A5 Inhibitors,CYP3A7 Inhibitors,Cytochrome P-450 CYP3A4 Inhibitors,Cytochrome P-450 CYP3A5 Inhibitors,Cytochrome P-450 CYP3A7 Inhibitors,P450 CYP3A Inhibitors,P450 CYP3A4 Inhibitors,P450 CYP3A5 Inhibitors,P450 CYP3A7 Inhibitors,CYP3A Inhibitor, P450,CYP3A4 Inhibitor, P450,CYP3A5 Inhibitor, P450,CYP3A5 Inhibitors, P450,CYP3A7 Inhibitor, P450,CYP3A7 Inhibitors, P450,Cytochrome P 450 CYP3A Inhibitor,Cytochrome P 450 CYP3A Inhibitors,Cytochrome P 450 CYP3A4 Inhibitor,Cytochrome P 450 CYP3A4 Inhibitors,Cytochrome P 450 CYP3A5 Inhibitor,Cytochrome P 450 CYP3A5 Inhibitors,Cytochrome P 450 CYP3A7 Inhibitor,Cytochrome P 450 CYP3A7 Inhibitors,Inhibitor, CYP3A,Inhibitor, CYP3A5,Inhibitor, CYP3A7,Inhibitor, Cyp3A4,Inhibitor, P450 CYP3A,Inhibitor, P450 CYP3A4,Inhibitor, P450 CYP3A5,Inhibitor, P450 CYP3A7,Inhibitors, CYP3A,Inhibitors, CYP3A4,Inhibitors, CYP3A5,Inhibitors, CYP3A7,Inhibitors, P450 CYP3A,Inhibitors, P450 CYP3A4,Inhibitors, P450 CYP3A7
D065701 Cytochrome P-450 CYP3A Inducers Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A. CYP3A4 Inducer,CYP3A Inducers,CYP3A4 Inducers,CYP3A5 Inducers,CYP3A7 Inducers,Cytochrome P-450 CYP3A4 Inducers,Cytochrome P-450 CYP3A5 Inducers,Cytochrome P-450 CYP3A7 Inducers,P450 CYP3A Inducers,P450 CYP3A4 Inducers,P450 CYP3A5 Inducers,P450 CYP3A7 Inducers,CYP3A4 Inducers, P450,Cytochrome P 450 CYP3A Inducers,Cytochrome P 450 CYP3A4 Inducers,Cytochrome P 450 CYP3A5 Inducers,Cytochrome P 450 CYP3A7 Inducers,Inducer, CYP3A4,Inducers, CYP3A,Inducers, CYP3A4,Inducers, CYP3A5,Inducers, CYP3A7,Inducers, P450 CYP3A,Inducers, P450 CYP3A4,Inducers, P450 CYP3A5,Inducers, P450 CYP3A7

Related Publications

Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Effect of oral contraceptives on plasma clearance.
December 1975, Clinical pharmacology and therapeutics,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
July 2001, Acta pharmacologica Sinica,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.
March 1999, Journal of clinical pharmacology,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children.
June 2019, The AAPS journal,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women.
January 2014, European review for medical and pharmacological sciences,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.
October 2020, Pharmacology research & perspectives,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Protective role of lipanthyl in women taking oral contraceptives.
January 1991, Therapia Hungarica (English edition),
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Depression and oral contraceptives: the role of pyridoxine.
October 1978, Drug and therapeutics bulletin,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
Migraine and stroke: the role of oral contraceptives.
May 2008, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Nan Zhang, and Jihong Shon, and Myong-Jin Kim, and Chongwoo Yu, and Lei Zhang, and Shiew-Mei Huang, and LaiMing Lee, and Doanh Tran, and Li Li
[Oral contraceptives and non-oral contraceptives: realities].
May 2009, Journal de gynecologie, obstetrique et biologie de la reproduction,
Copied contents to your clipboard!